{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:09:53Z","timestamp":1791950993072,"version":"4.3.4"},"reference-count":40,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Cardiovascular complications are the leading cause of death in type 2 diabetes mellitus (T2DM). We investigated whether blood-based DNA methylation (DNAm) biomarkers could improve risk stratification for major adverse cardiovascular events (MACE) in individuals with T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Epigenome-wide DNAm was profiled in peripheral blood mononuclear cells obtained at baseline from 305 T2DM participants of the Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents. Intervention Trial (TOSCA.IT) study, including 81 who experienced MACE within 5 years (T2DMACE) and 224 who did not (T2D). The population was randomly divided into training and internal test sets for model development and evaluation. Differential DNAm analyses were performed under five frameworks differing by covariate adjustment. Binomial least absolute shrinkage and selection operator (LASSO) logistic regression with stability selection was used to generate DNAm-based models to stratify individuals at higher risk of incident MACE over 5 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Differential DNAm analysis identified 23,839, 21,529, 21,500, 12,114, and 7,101 differentially methylated CpG sites across the five analytical frameworks. LASSO logistic regression was used to develop five DNAm-based models. Stability selection retained 22\u201326 CpG predictors per model. When evaluated in the internal test cohort, the five models showed high discriminative performance, with receiver operating characteristic area under the curve values ranging from 0.915 to 0.937 and area under the precision-recall curve values from 0.866 to 0.940. Several CpGs were independently associated with either increased or decreased risk of MACE, including 12 CpGs identified across all of the models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>The DNAm-based models we have generated may improve risk stratification for short-term cardiovascular events in individuals with T2DM, providing a promising approach to refine identification of those at increased risk of MACE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc26-0738","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:15:48Z","timestamp":1784222148000},"page":"1705-1713","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":1,"title":["Blood-Based DNA Methylation Models Improve Short-term Cardiovascular Risk Stratification in Individuals With Type 2 Diabetes"],"prefix":"10.2337","volume":"49","author":[{"given":"Michele","family":"Longo","sequence":"first","affiliation":[{"name":"Department of Translational Medicine, Federico II University of Naples 1 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Desiderio","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Federico II University of Naples 1 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Masulli","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Federico II University of Naples 2 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotirmoy","family":"Das","sequence":"additional","affiliation":[{"name":"Bioinformatics Unit, Core Facility (KEF), Faculty of Medical and Health Sciences (BKV), Link\u00f6ping University 3 , Link\u00f6ping, Sweden"},{"name":"Clinical Genomics Link\u00f6ping, SciLife Laboratory, Department of Biomedical and Clinical Sciences, Link\u00f6ping University 4 , Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Spinelli","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Federico II University of Naples 1 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Parrillo","sequence":"additional","affiliation":[{"name":"Institute of Endotypes in Oncology, Metabolism and Immunology, National Research Council 5 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacristina","family":"Rotondo","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Federico II University of Naples 1 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zatterale","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Federico II University of Naples 1 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Volpe","sequence":"additional","affiliation":[{"name":"Department of Immunotechnology, Faculty of Engineering (LTH), Lund University 6 , Lund, Sweden"},{"name":"National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Lund University 7 , Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Riccardi","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Federico II University of Naples 2 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vaccaro","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Federico II University of Naples 2 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Miele","sequence":"additional","affiliation":[{"name":"Institute of Endotypes in Oncology, Metabolism and Immunology, National Research Council 5 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3366-2321","authenticated-orcid":false,"given":"Raffaele","family":"Napoli","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Federico II University of Naples 1 , Naples, Italy"},{"name":"Department of Clinical Pathology, Laboratory Medicine and Virology, Federico II University Hospital 8 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4946-7803","authenticated-orcid":false,"given":"Francesco","family":"Beguinot","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Federico II University of Naples 1 , Naples, Italy"},{"name":"Department of Clinical Pathology, Laboratory Medicine and Virology, Federico II University Hospital 8 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2742-5634","authenticated-orcid":false,"given":"Gregory A.","family":"Raciti","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Federico II University of Naples 1 , Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"2026082014524992200_B1","unstructured":"World Health Organization\n          . Diabetes. WHO Fact sheet. Published 14 November 2024. Accessed 17 December 2025. Available from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes"},{"key":"2026082014524992200_B2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"2026082014524992200_B3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"2026082014524992200_B4","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"2026082014524992200_B5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs1010671","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"2026082014524992200_B6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"2026082014524992200_B7","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"2026082014524992200_B8","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2015.08.035","article-title":"10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study)","volume":"66","author":"McClelland","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026082014524992200_B9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12933-022-01603-8","article-title":"Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease","volume":"21","author":"Stevens","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2026082014524992200_B10","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","article-title":"SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe","volume":"44","author":"SCORE2-Diabetes Working Group; ESC Cardiovascular Risk Collaboration","year":"2023","journal-title":"Eur Heart J"},{"key":"2026082014524992200_B11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT Equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"2026082014524992200_B12","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.2337\/db13-1459","article-title":"Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes","volume":"63","author":"Nilsson","year":"2014","journal-title":"Diabetes"},{"key":"2026082014524992200_B13","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1038\/s41467-023-43719-9","article-title":"Genes with epigenetic alterations in human pancreatic islets impact mitochondrial function, insulin secretion, and type 2 diabetes","volume":"14","author":"R\u00f6nn","year":"2023","journal-title":"Nat Commun"},{"key":"2026082014524992200_B14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s43856-023-00250-8","article-title":"DNA methylation age acceleration is associated with risk of diabetes complications","volume":"3","author":"Vetter","year":"2023","journal-title":"Commun Med (Lond)"},{"key":"2026082014524992200_B15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13148-024-01670-6","article-title":"DNA methylation and type 2 diabetes: a systematic review","volume":"16","author":"Nadiger","year":"2024","journal-title":"Clin Epigenetics"},{"key":"2026082014524992200_B16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13148-023-01468-y","article-title":"DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites","volume":"15","author":"Krolevets","year":"2023","journal-title":"Clin Epigenetics"},{"key":"2026082014524992200_B17","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.117.027355","article-title":"Epigenome-wide Association study identifies cardiac gene patterning and a novel class of biomarkers for heart failure","volume":"136","author":"Meder","year":"2017","journal-title":"Circulation"},{"key":"2026082014524992200_B18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41374-018-0104-x","article-title":"Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure","volume":"99","author":"Pepin","year":"2019","journal-title":"Lab Invest"},{"key":"2026082014524992200_B19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/CIRCULATIONAHA.118.039357","article-title":"Blood leukocyte DNA methylation predicts risk of future myocardial infarction and coronary heart disease","volume":"140","author":"Agha","year":"2019","journal-title":"Circulation"},{"key":"2026082014524992200_B20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCULATIONAHA.124.073181","article-title":"DNA methylation signatures of cardiovascular health provide insights into diseases","volume":"152","author":"Carbonneau","year":"2025","journal-title":"Circulation"},{"key":"2026082014524992200_B21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/acel.12349","article-title":"DNA methylation and healthy human aging","volume":"14","author":"Jones","year":"2015","journal-title":"Aging Cell"},{"key":"2026082014524992200_B22","doi-asserted-by":"crossref","first-page":"14617","DOI":"10.1038\/ncomms14617","article-title":"DNA methylation signatures in peripheral blood strongly predict all-cause mortality","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"},{"key":"2026082014524992200_B23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41525-022-00320-1","article-title":"Methylation risk scores are associated with a collection of phenotypes within electronic health record systems","volume":"7","author":"Thompson","year":"2022","journal-title":"NPJ Genom Med"},{"key":"2026082014524992200_B24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41576-024-00807-w","article-title":"Epigenetic ageing clocks: statistical methods and emerging computational challenges","volume":"26","author":"Teschendorff","year":"2025","journal-title":"Nat Rev Genet"},{"key":"2026082014524992200_B25","doi-asserted-by":"crossref","first-page":"102290","DOI":"10.1016\/j.xcrm.2025.102290","article-title":"Epigenetic biomarkers predict macrovascular events in individuals with type 2 diabetes","volume":"6","author":"Garc\u00eda-Calz\u00f3n","year":"2025","journal-title":"Cell Rep Med"},{"key":"2026082014524992200_B26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S2213-8587(17)30317-0","article-title":"Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial","volume":"5","author":"Vaccaro","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082014524992200_B27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12864-019-5761-7","article-title":"Guidance for DNA methylation studies: statistical insights from the Illumina EPIC array","volume":"20","author":"Mansell","year":"2019","journal-title":"BMC Genomics"},{"key":"2026082014524992200_B28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jcmg.2024.12.004","article-title":"Vulnerable or high-risk plaque: a JACC: Cardiovascular Imaging position statement","volume":"18","author":"Vergallo","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026082014524992200_B29","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(24)00413-6","article-title":"Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial","volume":"403","author":"Park","year":"2024","journal-title":"Lancet"},{"key":"2026082014524992200_B30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jcin.2023.12.014","article-title":"Should we stent vulnerable, but asymptomatic, lesions?","volume":"17","author":"Johnson","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"2026082014524992200_B31","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1093\/eurheartj\/ehad583","article-title":"Economic burden of cardiovascular diseases in the European Union: a population-based cost study","volume":"44","author":"Luengo-Fernandez","year":"2023","journal-title":"Eur Heart J"},{"key":"2026082014524992200_B32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/hrt.2010.220442","article-title":"Cardiovascular risk scores do not account for the effect of treatment: a review","volume":"97","author":"Liew","year":"2011","journal-title":"Heart"},{"key":"2026082014524992200_B33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00125-021-05640-y","article-title":"Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings","volume":"65","author":"Dziopa","year":"2022","journal-title":"Diabetologia"},{"key":"2026082014524992200_B34","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf033","article-title":"The added value of ECG abnormalities in predicting incident cardiovascular disease risk for people with type 2 diabetes: the Hoorn Diabetes Care System cohort","author":"Harms","year":"2025","journal-title":"Eur J Prev Cardiol."},{"key":"2026082014524992200_B35","doi-asserted-by":"crossref","first-page":"1450610","DOI":"10.1155\/2022\/1450610","article-title":"lncRNA ADAMTS9-AS1\/circFN1 competitively binds to miR-206 to elevate the expression of ACTB, thus inducing hypertrophic cardiomyopathy","volume":"2022","author":"Feng","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"2026082014524992200_B36","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41431-023-01433-6","article-title":"A biallelic variant in COX18 cause isolated Complex IV deficiency associated with neonatal encephalo-cardio-myopathy and axonal sensory neuropathy","volume":"31","author":"Ronchi","year":"2023","journal-title":"Eur J Hum Genet"},{"key":"2026082014524992200_B37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ng.298","article-title":"The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores","volume":"41","author":"Irizarry","year":"2009","journal-title":"Nat Genet"},{"key":"2026082014524992200_B38","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/gb-2013-14-3-r21","article-title":"DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes","volume":"14","author":"Aran","year":"2013","journal-title":"Genome Biol"},{"key":"2026082014524992200_B39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"2026082014524992200_B40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2337\/db24-0483","article-title":"Blood-based","volume":"74","author":"Marchiori","year":"2025","journal-title":"Diabetes"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/9\/1705\/889093\/dc260738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/9\/1705\/889093\/dc260738.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:53:28Z","timestamp":1787252008000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/9\/1705\/172231\/Blood-Based-DNA-Methylation-Models-Improve-Short"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,16]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-0738","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}